US Archives - Page 5 of 137 - European Medical Journal

patient exercise monitoring

CHEST 2025: Improved Cardiac Function with Treprostinil in ASCENT Trial

Inhaled treprostinil treatment improved cardiac effort and physiological function in patients with pulmonary hypertension–interstitial lung disease.

infant receiving immunization in hospital

IDWeek 2025: RSV Shot After Birth Sparks Powerful Immunity

RSV immunization in infants is safe and produces high antibody levels, regardless of whether mothers received vaccination during pregnancy.

Illustration showing the human heart and pulmonary arteries, highlighting right ventricular function and pulmonary arterial hypertension.

CHEST 2025: GLP-1 Receptor Agonists Cut Right Heart Failure Risk

GLP-1 receptor agonists significantly reduced the risk of right heart failure in patients with pulmonary arterial hypertension compared with SGLT2-inhibitors.

Conceptual image showing the back of a person’s head and neck, symbolizing head and neck cancer care.

Improving Outcomes Through Coordinated Head and Neck Care

Transitions in care for patients with head and neck cancer remain a critical challenge, with new research revealing substantial evidence gaps.

Person wearing VR headset during mindfulness training with brain stimulation electrodes.

Combined Brain Stimulation and VR Improves Attention

A single session combining transcranial direct current stimulation and virtual reality-based mindfulness may enhance attention regulation.

Scientist performing laboratory microbiology testing with test tubes and pipette to analyze respiratory samples in a biosafety cabinet.

Nasal Irrigation Rivals Sputum Testing in Cystic Fibrosis

Nasal irrigation could provide a practical, non-invasive alternative for monitoring airway microbiology in people with cystic fibrosis.

Healthcare professional preparing HIV preventive treatment injection; close-up of lenacapavir vial and syringe; concept of affordable HIV prevention and global treatment access

IDWeek 2025: HIV Prevention Breakthrough Could Cost $25 Annually

A new study presented at IDWeek 2025 suggests that HIV preventive treatment with lenacapavir could be produced for as little as $25 per patient per year.

Nebulized therapy concept for COPD symptom relief with ensifentrine

CHEST 2025: Ensifentrine Boosts Quality of Life in COPD

Ensifentrine improved symptoms, dyspnea, and quality of life in stable COPD without exacerbations in ENHANCE trials.

Cardiopulmonary exercise test assessing cardiorespiratory fitness in psoriatic arthritis

Psoriatic Arthritis Shows Lower Cardiorespiratory Fitness Levels

Cross-sectional testing shows reduced cardiorespiratory fitness in psoriatic arthritis, with disease activity and adiposity linked to lower VO2peak and self-reported activity linked to higher fitness.

Older adult receiving RSV vaccination in a clinical setting to prevent acute respiratory illness.

RSV Vaccine Cuts Severe Illness in Seniors

RSV vaccine effectiveness in older adults reached high levels against acute respiratory illness in 2023–2024 postlicensure testing.